Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in Glioblastoma.
Aldaz P, Auzmendi-Iriarte J, Durántez M, Lasheras-Otero I, Carrasco-Garcia E, Zelaya MV, Bragado L, Olías-Arjona A, Egaña L, Samprón N, Morilla I, Redondo-Muñoz M, Rico M, Squatrito M, Maria-Alonso M, Fernández-Irigoyen J, Santamaria E, Larráyoz IM, Wellbrock C, Matheu A, Arozarena I. Aldaz P, et al. Among authors: wellbrock c. Cancers (Basel). 2021 Jan 19;13(2):361. doi: 10.3390/cancers13020361. Cancers (Basel). 2021. PMID: 33478100 Free PMC article.
Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma.
Smith MP, Ferguson J, Arozarena I, Hayward R, Marais R, Chapman A, Hurlstone A, Wellbrock C. Smith MP, et al. Among authors: wellbrock c. J Natl Cancer Inst. 2013 Jan 2;105(1):33-46. doi: 10.1093/jnci/djs471. Epub 2012 Dec 17. J Natl Cancer Inst. 2013. PMID: 23250956 Free PMC article.
Targeting MITF in the tolerance-phase.
Arozarena I, Smith MP, Wellbrock C. Arozarena I, et al. Among authors: wellbrock c. Oncotarget. 2016 Aug 23;7(34):54094-54095. doi: 10.18632/oncotarget.9423. Oncotarget. 2016. PMID: 27528022 Free PMC article. No abstract available.
Targeting invasive properties of melanoma cells.
Arozarena I, Wellbrock C. Arozarena I, et al. Among authors: wellbrock c. FEBS J. 2017 Jul;284(14):2148-2162. doi: 10.1111/febs.14040. Epub 2017 Mar 1. FEBS J. 2017. PMID: 28196297 Free article. Review.
Overcoming resistance to BRAF inhibitors.
Arozarena I, Wellbrock C. Arozarena I, et al. Among authors: wellbrock c. Ann Transl Med. 2017 Oct;5(19):387. doi: 10.21037/atm.2017.06.09. Ann Transl Med. 2017. PMID: 29114545 Free PMC article. Review.
65 results